fda compounding semaglutide crackdown 2025 news September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines FDA proposes a new GLP-1

According to the National Institute for Health and Care Excellence (NICE) guideline NG28, GLP-1 receptor agonists like Ozempic are typically recommended as part of triple therapy regimens for type 2 diabetes under specific criteria, including BMI considerations and when other treatments have not achieved glycaemic targets

you wont have to suppress your appetite because your body just doesnt want to over-indulge)

Hsiao is on the board of directors for the Hidradenitis Suppurativa Foundation, and has served as an advisor, investigator, and/or speaker for AbbVie, Aclaris, AstraZeneca, Boehringer Ingelheim, Galderma, Incyte, Novartis, Pfizer, Regeneron, Sanofi, and UCB

a single miss is clinically minimal